America's pharmaceutical research companies are testing 92 medicines and vaccines to treat or prevent HIV/AIDS and related conditions.

The leading Republican and Democratic presidential candidates are proposing two very different approaches to reform the U.S. healthcare system, according to an analysis released today by PricewaterhouseCoopers’ Health Research Institute

As health benefit costs per employee rises 6.1 percent for third year, percentage of employers offering coverage continues to drop.

Quark Pharmaceuticals, Inc., announced today that it has commenced systemic dosing in humans of its proprietary product candidate, AKIi-5, a siRNA compound discovered and developed by Quark for the treatment of Acute Renal Failure (ARF).

Kline Report on Smart Coatings Cites Immediate Opportunities in Antimicrobial Coatings, Cool Paint, and Smart Glass.